Seven and Eight Biopharmaceuticals Inc.
PrivateCompany Overview
Seven and Eight Biopharmaceuticals Inc. is a biotechnology company that develops novel immuno-oncology therapies targeting toll-like receptors to treat cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Seven and Eight Biopharmaceuticals Inc. Comparables
Compare Seven and Eight Biopharmaceuticals Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eikon Therapeutics | 82% | |
| Inimmune | 81% | |
| Primmune Therapeutics | 80% |
For institutional investors. Book with your work email.
Seven and Eight Biopharmaceuticals Inc. Funding Rounds
Historical fundraising activity
Seven and Eight Biopharmaceuticals Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Seven and Eight Biopharmaceuticals Inc.'s valuation, stock price, and market status.
Is Seven and Eight Biopharmaceuticals Inc. a public or private company?
Seven and Eight Biopharmaceuticals Inc. is a private company.
What is the current stock price of Seven and Eight Biopharmaceuticals Inc.?
Seven and Eight Biopharmaceuticals Inc. is a private company, so its shares have no public market price. Caplight tracks Seven and Eight Biopharmaceuticals Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Seven and Eight Biopharmaceuticals Inc. worth (valuation)?
Valuation information for Seven and Eight Biopharmaceuticals Inc. is not publicly available.
Can I buy Seven and Eight Biopharmaceuticals Inc. stock?
Seven and Eight Biopharmaceuticals Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Seven and Eight Biopharmaceuticals Inc.'s last funding round?
Funding round information for Seven and Eight Biopharmaceuticals Inc. is not publicly available.
Who are the main investors in Seven and Eight Biopharmaceuticals Inc.?
Investor information for Seven and Eight Biopharmaceuticals Inc. is not publicly disclosed.
Will Seven and Eight Biopharmaceuticals Inc. IPO soon?
No public IPO plans have been announced for Seven and Eight Biopharmaceuticals Inc..
How can I track Seven and Eight Biopharmaceuticals Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Seven and Eight Biopharmaceuticals Inc.'s shares on secondary markets.